Hypomagnesaemia leading to parathyroid dysfunction, hypocalcaemia, and hypokalaemia as a complication of long-term treatment with a proton pump inhibitor — a literature review
Endokrynologia Polska · 2024
DOI: 10.5603/ep.98576 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endokrynologia Polska, 2024. Verfasst von Małgorzata Bobrowicz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Hypocalcemia, Hypokalemia. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland.
- Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
- michal.popow@uckwum.pl.
Zitieren
APA
Bobrowicz, M., Pachucki, J., & Popow, M. (2024). Hypomagnesaemia leading to parathyroid dysfunction, hypocalcaemia, and hypokalaemia as a complication of long-term treatment with a proton pump inhibitor — a literature review. Endokrynologia Polska. https://doi.org/10.5603/ep.98576
Vancouver
Bobrowicz M, Pachucki J, Popow M. Hypomagnesaemia leading to parathyroid dysfunction, hypocalcaemia, and hypokalaemia as a complication of long-term treatment with a proton pump inhibitor — a literature review. Endokrynologia Polska. 2024. doi:10.5603/ep.98576
BibTeX
@article{Bobrowicz2024,
author = {Bobrowicz, Małgorzata and Pachucki, Janusz and Popow, Michał},
title = {Hypomagnesaemia leading to parathyroid dysfunction, hypocalcaemia, and hypokalaemia as a complication of long-term treatment with a proton pump inhibitor — a literature review},
journal = {Endokrynologia Polska},
year = {2024},
doi = {10.5603/ep.98576}
}
EUVIMED